Introduction
============

Obesity represents a major health problem: Its incidence is growing all over the world and it is associated with an increased risk of cardiovascular disease, type II diabetes mellitus, hypertension, heart attack, dyslipidemia, osteoarthritis and several cancers ([@b1-mco-0-0-1901]).

Worldwide, the number of obese people has doubled since 1980: In 2014, over 1.9 billion adults were overweight, including over 600 million obese ([@b1-mco-0-0-1901]). Data referring to the year 2013 show that in Europe over 50% of the adult population was overweight and over 20% was obese ([@b2-mco-0-0-1901]). The Italian Public Report on National Health shows that in 2015, more than a third of the adult population (35.3%) was overweight, and 9.8% of persons were obese; of note, the percentage of excess-weight population increases with age, and in the Italian context, overweight and obesity increase from 14 and 2.3% at 18--24 years of age to 46 and 15.3% in the category of patients between 65--74 years, respectively ([@b3-mco-0-0-1901]). In a cross-sectional analysis, Arterburn *et al* reported that morbid obesity (BMI≥40 kg/m^2^) is associated with an 81% greater health care expenditure per capita compared with normal weight adults in the US, with an excess of more than 11 billion dollars spent per year ([@b4-mco-0-0-1901]). Moreover, obesity is actually associated with huge indirect costs, due to the co-existence of several co-morbidities (diabetes, hypertension, cardiovascular problems), need for intense preoperative assessments, perioperative complications, conversion from laparoscopic to open surgery, intensive postoperative care (IPC), higher treatment costs and reduced recurrence-free survival ([@b5-mco-0-0-1901],[@b6-mco-0-0-1901]). Obesity is now considered a global epidemic; in a society that is increasingly trying to reduce health-care expenses, it is essential to analyze the costs associated with the management of these patients.

Endometrial cancer is the most common gynecological malignancy in Western countries and most of these tumors are associated with obesity ([@b7-mco-0-0-1901],[@b8-mco-0-0-1901]). As a consequence, the increasing prevalence of obesity translates into a growth in the incidence of endometrial cancer. Since the early ′90 sec, several authors have reported their experience with laparoscopic treatment of clinical stage I endometrial cancer ([@b9-mco-0-0-1901]--[@b11-mco-0-0-1901]). After the publication of the results of the LAP-2 trial, laparoscopy has become the elective treatment for this malignancy, due to the more favorable complication rates, the shorter hospital stay and the similar oncological outcomes, compared to open surgery ([@b12-mco-0-0-1901]).

From a surgical point of view the obese woman turns out to be a complex patient; in fact, the laparoscopic learning curve is harsher than for normal-weight subjects, especially when lymphadenectomy is to be performed ([@b13-mco-0-0-1901],[@b14-mco-0-0-1901]). Some studies report that in 10% of cases the obese patient is inoperable for the presence of medical comorbidities and in \~20% of cases the affected woman is under-staged due to surgical complexity ([@b15-mco-0-0-1901]--[@b17-mco-0-0-1901]).

Robotic surgery has been proposed to overcome some of the difficulties in operating obese patients, maintaining the same benefits of laparoscopic surgery and providing a better exposure of the operative field, although it may be disadvantageous with respect to economic considerations ([@b18-mco-0-0-1901]).

Although several studies have investigated costs of laparoscopic vs. open approach for endometrial cancer, very few data are available in selected population of patients, such as obese women ([@b19-mco-0-0-1901]--[@b22-mco-0-0-1901]).

The aim of this study has been to evaluate pre-, intra- and post-operative costs in obese women affected by endometrial cancer comparing laparoscopic vs. open abdominal surgery. As a secondary outcome, we evaluated the feasibility of laparoscopic surgery in obese women analyzing intraoperative, early and late postoperative complications, in comparison with open surgery.

Patients and methods
====================

The present study represents a retrospective analysis of the oncological database of the Gynecology and Obstetrics Department of the University Hospital of Parma from January 2007 to December 2017. Five-hundred-forty patients underwent surgery for endometrial cancer in the study period. Of them, 132 (24.4%) were obese (BMI≥30). These subjects were included in the study and they were divided into two groups (laparoscopic and open abdominal), according to the initial surgical approach. Patients were stratified into the four different classes of obesity \[class I (\<35), class II (\<40), class III (\<45), class IV (\>45) ([@b23-mco-0-0-1901],[@b24-mco-0-0-1901])\]. Patients characteristics are shown in [Table I](#tI-mco-0-0-1901){ref-type="table"}.

Before December 2015, lymphadenectomy was performed in case of grade 2--3 disease and/or myometrial invasion \>50%. After December 2015, lymph node dissection was accomplished in selected cases according to the ESGO-ESMO-ESTRO consensus conference recommendations ([@b25-mco-0-0-1901]).

The patients were operated by laparoscopy or open surgery according to the preference and experience of the surgeons involved. Two expert oncologist surgeon gynecologists were included during the study period.

### Preoperative phase

Medical history and clinical characteristics were collected in all patients pre-operatively. Preoperative work-up included blood tests, electrocardiogram, blood gas analysis and Total Body CT scan. In case of comorbidities, further examinations and consultations were requested such as spirometry, echocardiogram, lower limb eco-Doppler, chest X-ray, urine test, cardiology, endocrinology or internal medicine counseling.

### Operative technique

Access into the abdominal cavity was obtained using a 10-mm optical trocar inserted transumbilically. Pneumoperitoneum was maintained at 12 mm Hg. Three 5 mm ancillary trocars were inserted in the suprapubic area. All patients underwent class. A Hysterectomy according to Q-M classification ([@b26-mco-0-0-1901]) and bilateral salpingo-oophorectomy. Pelvic and aortic lymphadenectomy were performed, depending on the case as previously specified. In selected cases, suspension of the sigmoid and cecum was accomplished to obtain a better exposure of the operative field. A Rumi uterine manipulator was used ([@b27-mco-0-0-1901]). The maximum Trendelemburg tolerated by the patient was applied.

Laparotomy was performed with a vertical midline incision. The surgical steps resembled those of laparoscopic surgery.

### Postoperative phase

The days of hospitalization, intensive care admission, number of blood tests and blood counts, use of thromboembolism therapy (elastic stockings and/or low molecular weight heparin), early postoperative complications (within 30 days from surgery) and late (over 30 days from surgery), request for specialist advice, possible oxygen therapy, instrumental examinations, possible antibiotic therapy, pain reliever type, were analyzed for both groups. Complications were classified according to the glossary of Chassagne and colleagues ([@b28-mco-0-0-1901]).

### Analysis of costs

In order to make a comprehensive and precise cost analysis, we considered the single cost of each day spent in the different units (gynecology department and intensive care unit) and they were added to the cost of the surgery (laparoscopy vs. laparotomy) and all the single drug administrations (ie. type of medication received, number of actual administrations), other specialists\' consultations, blood samples, imaging exams.

Regarding operative devices such as multifunction instruments, the total cost of all the single pieces used was calculated and then the average per capita expenditure was obtained.

All costs are expressed in euros (€). They are updated to December 2017 and refer to the University Hospital of Parma in Emilia Romagna, Italy.

The costs of each benefit were provided by the General Directorate of the Hospital-University of Parma and the costs were adjusted for inflation. No reimbursement was asked to the patients, and the total cost was borne by the hospital-University of Parma.

In order to obtain a more complete and closer to reality estimate of the cost of an obese patient, the pre-operative costs were also included, although clearly these do not depend on the surgical approach but on the patient\'s comorbidities.

### Statistical analysis

Continuous variables have been described as mean ± standard deviation (DS). The same variables were initially analyzed with D\'Agostino-Pearson tests to explore the distribution compared to a normal population. In the case of a test result with a value of P\>0.100, the variables were considered normally distributed, and the comparison between them was performed with the Student\'s t test or or one-way Analysis of Variance (ANOVA) with Tukey\'s post-hoc test, where appropriate. In the case of a test result with a value of P\<0.100, the population was considered not normally distributed, and consequently the comparison was performed using statistical tests independent of variance, i.e. determination of the Mann-Whitney U or Wilcoxon\'s signed rank test, where appropriate.

The categorical variables have been described as percentages and compared with a chi-square test with Yates correction due to the limited number of subjects. A value of P=0.05 was considered statistically significant.

Results
=======

### Results

Of the 132 obese patients selected, 77 (58.3%) underwent laparoscopy and 55 (41.3%) laparotomy. The mean age of patients at the time of diagnosis was 65.4 years.

The patients\' demographic characteristics are shown in [Table I](#tI-mco-0-0-1901){ref-type="table"}. The average body mass index (BMI) was 35.9 kg/m^2^ (range 30.08--60.97 kg/m^2^). Class I, II, III and IV of obesity were present in 53.2 vs. 52.7%, 24.7 vs. 27.3%, 14.3 vs. 14.5%, and 7.8 vs. 5.5% for the laparoscopic vs. open abdominal groups, respectively.

The most frequent comorbidity reported was hypertension (70.56%), followed by diabetes (44.33%), cardiovascular disease (22.7%), metabolic syndrome (20.5%) and hypothyroidism (20.5%). The latter condition was significantly more frequent in the open abdominal than in the laparoscopic group (P=0.006). In 68.2% of the cases, endometrial cancer occurred at stage IA disease and in 65.2% the neoplasms were graded G1. Of the 90 patients diagnosed at stage IA, 62 (68.9%) underwent laparoscopic surgery and 28 (31.1%) open abdominal surgery with a statistically significant difference in the distribution within the two groups (P=0.002). Stage and grading in the two groups are shown in [Table II](#tII-mco-0-0-1901){ref-type="table"}.

### Pre-operative phase

Chest X-ray (P\<0.001), lower limb eco-Doppler (P=0.047) and chemical urinalysis (P\<0.001) were required more often in the open surgery group. In terms of costs, the median expenditure per patient was €1.93 vs. €12.85 for X-ray, €9.12 vs. €15.96 for eco-Doppler and €0.74 vs. €2.4 for chemical examination of urine in the laparoscopic and open abdominal groups respectively.

The median total cost of pre-operative examinations for each single patient was €11.79 and €31.21 in the laparoscopic and open abdominal groups, respectively, with a difference of €19.42 in favor of the laparoscopic group.

### Intra-operative phase

Intraoperative details are shown in [Table III](#tIII-mco-0-0-1901){ref-type="table"}. Operative time was shorter in the laparoscopic group. A statistical analysis of the average hourly cost of the operating room was not performed because the University Hospital of Parma is a public facility and it doesn\'t influence the overall cost of the operation.

At the University Hospital of Parma, the instrumentation and the surgical materials used during the laparoscopic procedures performed costed €511.27 compared to €420.36 for laparotomy.

Of the 56 patients undergoing lymphadenectomy, 20 patients were submitted to laparoscopy and 36 (with lumboaortic lymphadenectomies) to laparotomy (P\<0.001). Cost of lymphadenectomy has been included as part of the overall costs of the surgical procedure itself.

The need for peritoneal drainage was lower in the laparoscopic group (64.9 vs. 100%), with a median cost per capita of €7.63 vs. €11.75.

Overall, 5.2% of patients operated by laparoscopy required placement of a central venous catheter, compared to 25.5% of patients who underwent laparotomy (P=0.001), with a median cost of €3.11 vs. €15.24, respectively.

Total intraoperative cost for laparoscopy and laparotomy was €755.09 and €969.13, respectively, with an excess of €214.04 in the laparotomy group.

No difference was found in terms of intraoperative complications (vascular, bladder or intestinal lesions) between the two groups (13 vs. 18.2% in the laparoscopic and open abdominal group, respectively; P=0.566).

### Post-operative phase

Details of the postoperative course are provided in [Table IV](#tIV-mco-0-0-1901){ref-type="table"}. The average length of stay was longer for patients operated by laparotomy: 9.4 days compared to 5.1 days for patients operated by laparoscopy (P=0.683). This implied an almost double median hospitalization cost in the open abdominal group compared to the laparoscopic group (€4805.37 vs. €2589.25; P\<0.0001).

Eighteen patients required intensive care hospitalization. The median cost per capita was €233.08 for laparoscopy and €512.78 for laparotomy (P=0.090).

Of the 9 total patients who required a transfusion of concentrated red cells, 8 were part of the open abdominal group. The average expenditure per patient in terms of blood bags transfused was €39.49 for the open abdominal arm compared to €3.53 in the laparoscopic group (P=0.003). The hemoglobin drop was 0.5 g/dl in the open abdominal group vs. 0.3 g/dl in the laparoscopic group. Also the number of blood tests (P\<0.001), blood count (P\<0.001), hemogasanalysis (P=0.001), tests of hemostatic control function (P\<0.001) were higher in the open abdominal group. [Table IV](#tIV-mco-0-0-1901){ref-type="table"} shows that postoperative electrocardiogram (P\<0.001), CT scan (P=0.034), and chest X-ray (P\<0.001) were more frequent in the open abdominal arm with a consequent increase of the costs per capita.

Evaluation by another specialist (cardiologist, diabetologist, internist) was necessary in 30.9% of laparotomies vs. 10.4% of laparoscopies (P=0.003), with an expense of €18.71 vs. €11. 45 respectively.

A respiratory support was applied to 38 patients (28.8%), of whom 23 (41.8%) were in the open abdominal arm (P=0.011). Oxygen therapy entailed a medical health expenditure of €4.05 in the open abdominal group vs. €2.97 of minimally invasive surgery. No difference in costs was shown in the antithrombotic prophylaxis in the two arms, with a median cost of €37.88.

No significant difference was found also in terms of post-operative antibiotic therapy. Considering pain control, after laparotomy the most used drugs were Morphine (36.4%), Ropivacain (20%) and Ketoprofen (45.5%). Following laparoscopic surgery, the most frequently used drugs were Paracetamol (80.5%) and Ketorolac (41.6%). Antibiotic and pain-relief therapies resulted in a significantly higher cost for the open abdominal than for the minimally-invasive approach, with a cost for each patient of €5.40 vs. €3.71, respectively (P=0.027).

The cost of a single gynecological examination is €18.00. Thirty-two total gynecological checks were performed outside the standard follow-up visits. Twenty-three patients operated by laparotomy required extra gynecological post-operative controls, vs. 9 patients in the laparoscopic group. The average cost for post-operative gynecological check-ups was €7.53 and €2.10 for the open and laparoscopic groups, respectively.

Comparing the two surgical techniques, minimally invasive surgery appeared to be more advantageous in terms of post-operative overall costs, with an average cost of €3646.53 vs. €6322.83 in the open technique (P\<0.0001). Therefore, median post-operative costs for single patient was €2676.30 higher in the laparotomy group.

Both early (P\<0.01) and late (P=0.072) complications were more frequently observed in the open abdominal group, as shown in [Table V](#tV-mco-0-0-1901){ref-type="table"}. Among the early complications only the dehiscence of the surgical wound reached statistical significance (12.7% vs. no cases in the open and laparoscopic groups, respectively). The most frequent major postoperative complication was represented by incisional hernia \[14.5% of patients who underwent laparotomy compared to 5.2% of patients who had laparoscopy (P=0.065)\].

Considering all the pre-, intra- and post-operative course, the expenses for an obese patient operated by laparoscopy was €4412.41 vs. €7323.17 by open surgery, with an average saving of €2911.03 in favor of minimally-invasive surgery (see [Table VI](#tVI-mco-0-0-1901){ref-type="table"}).

Discussion
==========

As expected, in our series we observed a median excess expenditure of €2911.03 per capita for obese patients operated by laparotomy compared to laparoscopy. Therefore, the present study shows that minimally invasive surgery is more advantageous both in terms of costs and of patients\' outcomes, compared to traditional open surgery.

The results obtained in our study are in line with others that have reported an economic advantage when using a laparoscopic technique ([@b18-mco-0-0-1901],[@b19-mco-0-0-1901],[@b27-mco-0-0-1901],[@b29-mco-0-0-1901]). While most of the previous studies have analyzed the difference between the costs of obese patients compared to non-obese patients or laparoscopy compared to laparotomy in the overall populations, our study compares the two surgical approaches analyzing only the subset of obese patients. Even more importantly, our study has the merit of a detailed and comprehensive evaluation of all the direct and indirect costs connected to the different surgical procedures.

An important aspect of our analysis is that the demographic distribution of our patients is homogeneous in the two groups in terms of comorbidity, age, BMI classes, menopausal status and ASA score.

The cost analysis was divided into the pre-, intra- and post-operative phases to better understand in which setting there is a greater expense in one vs. the other technique. These data may allow a better understanding regarding the possibility of improving the management of these specific patients.

As expected, expenditure in the preoperative phase is almost superimposable in the two groups, given the similar demographic characteristics of the patients included. In the intra- and post-operative phase, the major economic differences were mainly due to the increased of laparotomy and to the higher incidence of postoperative complications and admission to intensive care unit in the open abdominal technique.

As a secondary aim of the present study we observed, in line with the LAP2 study, that laparoscopy turns out to be a safe surgical technique in terms of intraoperative and postoperative complications ([@b12-mco-0-0-1901]). Pelvic lymphadenectomy was performed in 56 total patients, 20 were patients in the laparoscopic group and 34 in the open group. Only 2 patients underwent aortic lymphadenectomy and were included in the traditional abdominal surgery. This may reflect the fact that 80.5% of the patients in the laparoscopic group had stage IA disease vs. 50.9% in the open abdominal group. Of course, this finding may be associated with an inherent selection bias of our retrospective study, i.e. the tendency to operate by open surgery patients at a more advanced stage.

Regarding the other possible limitations of our study, we mention its retrospective nature, the very long study period (with a wide variation in terms of implementation of laparoscopic techniques) and the fact that the choice regarding the surgical approach, was made at surgeons\' discretion. Nonetheless, in a secondary analysis based on the intention-to-treat principle, we observed that still laparoscopy was associated with a saving of \> €2500 per patient.

On the other hand, our study has also several merits: It should be stressed that we selected only obese patients, thus providing more focused and useful data, in a population of patients which is rapidly increasing. Patients with a similar incidence of comorbidities were included in the two groups. Surgical techniques have been standardized and only two surgeons (with extensive background in gynecologic oncologic surgery) were involved. Finally, our cost-analysis has been extremely thorough and detailed, and allowed us to provide reliable and realistic data.

In conclusion, this study demonstrates that minimally invasive techniques are preferable to open surgery both in terms of cost per patient and in terms of peri-operative complications in the setting of obese patients. For every woman operated by laparoscopy at the university of Parma more almost 3000 EUR have been saved compared to laparotomy. These findings should be taken into account in an era in which technological innovations have to be balanced against a strong attention to health care costs.
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###### 

Patient demographics (N=132).

                                All patients   Laparoscopy   Laparotomy   
  ----------------------------- -------------- ------------- ------------ -------
  Age (years)                   65.4           66.0          64.6         0.430
  Menopause                     118 (89.4%)    72 (93.5%)    46 (83.6%)   0.069
  Age of menopause (years)      51.4           51.1          51.8         0.389
  Body mass index (kg/m^2^)     35.9           35.8          36.2         0.683
  \<35                          70 (53.0%)     41 (53.2%)    29 (52.7%)   0.951
  35--40                        34 (25.8%)     19 (24.7%)    15 (27.3%)   
  41--45                        19 (14.4%)     11 (14.3%)    8 (14.5%)    
  \>45                          9 (6.8%)       6 (7.8%)      3 (5.5%)     
  Comorbidity                   112 (84.8%)    66 (85.7%)    46 (83.6%)   0.743
  Hypertension                  93 (70.5%)     58 (75.3%)    35 (63.6%)   0.147
  Diabetes                      44 (33.3%)     21 (27.3%)    23 (41.8%)   0.081
  Cardiovascular diseases       30 (22.7%)     13 (16.9%)    17 (30.9%)   0.058
  Hypothyroidism                27 (20.5%)     22 (28.9%)    5 (9.1%)     0.006
  Metabolic syndrome            27 (20.5%)     17 (22.1%)    10 (18.2%)   0.584
  Chronic pulmonary disease     2 (1.5%)       1 (1.3%)      1 (1.8%)     0.810
  Hemiplegia or paraplegia      2 (1.5%)       1 (1.3%)      1 (1.8%)     0.810
  Hyperthyroidism               2 (1.5%)       0, -          2 (3.6%)     0.092
  HBV/HCV/HIV                   2 (1.5%)       1 (1.3%)      1 (1.8%)     0.810
  Mutation of Leiden V factor   1 (0.8%)       1 (1.3%)      0, -         0.396
  Nephrolithiasis               1 (0.8%)       1 (1.3%)      0, -         0.396
  Neurological disease          1 (0.8%)       1 (1.3%)      0, -         0.396
  ASA score                                                               
  2                             55 (41.7%)     33 (50.0%)    22 (40.7%)   0.311
  3                             65 (49.2%)     33 (50.0%)    32 (59.3%)   

###### 

Tumors staging and grading.

            All patients   Laparoscopy   Laparotomy   
  --------- -------------- ------------- ------------ -------
  Staging                                             0.002
    IA      90 (68.2%)     62 (80.5%)    28 (50.9%)   
    IB      29 (22.0%)     12 (15.6%)    17 (30.9%)   
    II      4 (3.0%)       0 (%)         4 (7.3%)     
    III     3 (2.3%)       2 (2.6%)      1 (1.8%)     
    IV      6 (4.5%)       1 (1.3%)      5 (9.1%)     
  Grading                                             0.081
    G1      86 (65.2%)     56 (72.7%)    30 (54.5%)   
    G2      33 (25.0%)     16 (20.8%)    17 (30.9%)   
    G3      13 (9.8%)      5 (6.5%)      8 (14.5%)    

###### 

Intraoperative phase.

                                          All patients   Laparoscopy   Laparotomy   
  --------------------------------------- -------------- ------------- ------------ ---------
  Operative time (min)                    156.8          117.0         212.5        \<0.001
  Intraoperative complications            20 (15.2%)     10 (13.0%)    10 (18.2%)   0.566
  Use of drainage                         105 (79.5%)    50 (64.9%)    55 (100%)    \<0.001
  Placement of central venous catheters   18 (13.6%)     4 (5.2%)      14 (25.5%)   0.001
  Use of intraoperative drugs             11 (8.3%)      7 (9.0%)      4 (7.2%)     0.413

###### 

Post-operative phase.

                                    All patients   Laparoscopy   Laparotomy   
  --------------------------------- -------------- ------------- ------------ ---------
  Hospital stay (days)              6.9            5.1           9.4          0.683
  Critical care unit (any access)   18 (13.6%)     7 (9.1%)      11 (20.0%)   0.072
  Total blood count (number)        2.9            2.1           3.8          \<0.001
  Blood trasfusion                  9 (6.8%)       1 (1.3%)      8 (14.5%)    0.003
  Thromboembolism therapy           131 (99.2%)    77 (100%)     54 (98.2%)   0.232
  Early complications (\<30 days)   50 (37.9%)     18 (23.4%)    32 (58.2%)   \<0.001
  Late complications (\>30 days)    18 (13.6%)     7 (9.1%)      11 (20.0%)   0.072
  Medical consultations             25 (18.9%)     8 (10.4%)     17 (30.9%)   0.003
  Respiratory support (any)         38, 28.8%      15, 19.5%     23 (41.8%)   0.011
  Antibiotic therapy                12 (9.1%)      6 (7.8%)      6 (10.9%)    0.539
  Pain reliever therapies                                                     
    *Naropine*                      12 (9.1%)      1 (1.3%)      11 (20.0%)   \<0.001
    *Ketoprophene*                  45 (34.1%)     20 (26.0%)    25 (45.5%)   0.020
    *Morphine*                      28 (21.2%)     8 (10.4%)     20 (36.4%)   \<0.001
    *Toradol*                       43 (32.6%)     32 (41.6%)    11 (20.0%)   0.009
    *Perfalgan*                     91 (68.9%)     62 (80.5%)    29 (52.7%)   0.001
  CT scan                           7 (5.3%)       1 (103%)      6 (10.9%)    0.015
  EEG                               34 (25.8%)     27 (49.1%)    7 (9.1%)     \<0.001
  Chest X-ray                       20 (15.2%)     4 (5.2%)      16 (29.1%)   \<0.001

CT, computed tomography scan; ECG, electrocardiography.

###### 

Complications.

                                 All patients   Laparoscopy   Laparotomy   
  ------------------------------ -------------- ------------- ------------ -------
  Respiratory distress           15 (11.4)      6 (7.8%)      9 (16.4%)    0.578
  Hypertensive crisis            10 (7.6)       5 (6.5%)      5 (9.1%)     0.578
  Anemia                         9 (6.8)        4 (5.2%)      5 (9.1%)     0.397
  Systemic infections            4 (3.0)        2 (2.6%)      2 (3.6%)     0.810
  Deep vein thrombosis           2 (1.5)        0 (%)         2 (3.6%)     0.092
  Surgical site infections       3 (2.3)        1 (1.3%)      2 (3.6%)     0.374
  Surgical site dehiscence       7 (5.3)        0 (%)         7 (12.7%)    0.001
  Late complications (any)       18 (13.6)      7 (9.1%)      11 (20.0%)   0.072
  Laparocele/incisional hernia   12 (9.1)       4 (5.2%)      8 (14.5%)    0.065

Early complications, within 30 days from surgery; Late complications, over 30 days from surgery.

###### 

Total costs (means).

                                     All patients   Laparoscopy   Laparotomy   
  ---------------------------------- -------------- ------------- ------------ ----------
  Hospital stay                      3512.63        2589.25       4805.37      \<0.0001
  Operation costs                    477.26         511.27        420.36       \<0.0001
  Critical care unit                 349.62         233.08        512.78       0.090
  Medical consultations              14.47          11.45         18.71        0.062
  Blood exams                        214.24         17.55         269.82       \<0.0001
  Deep vein thrombosis prophylaxis   37.88          38.96         36.36        0.171
  O2 therapy                         3.42           2.97          4.05         0.593
  Drugs therapy                      4.41           3.71          5.40         0.027
  Blood transfusion                  18.41          3.53          39.49        0.010
  Drainage                           9.35           7.63          11.75        \<0.0001
  Central venous access              8.16           3.11          15.24        0.002
  X-ray                              9.58           2.90          18.94        \<0.0001
  MRI                                37.80          32.40         45.35        0.416
  CT                                 9.28           2.27          19.10        0.034
  ECG                                4.36           1.30          8.63         \<0.0001
  Echocardiography                   7.82           7.38          8.45         0.745
  Doppler lower limbs                11.97          9,12          15.96        0.055

MRI, magnetic resonance imaging; CT, computed tomography scan; ECG, electrocardiography.
